JAMA Internal Medicine Submission Guide: Fit, Evidence, and First Files

We reviewed JAMA Internal Medicine's current author-facing material on July 13, 2026. It identifies an international journal for research relevant to general internal medicine and its subspecialties, and it describes the journal's emphasis on clinical relevance, clinical practice change, credibility, and convincing communication. It also links authors to the live instructions and submission system.

We separate those publisher statements from Manusights interpretation. The practical pre-submission test below asks what an editor and a clinician-reader can actually inspect: the decision affected, the population, the comparator or exposure, the outcome, the analysis, and the limit on the conclusion. It is not a promise of external review, a hidden score, or a replacement for the official article-type rules.

JAMA Internal Medicine is not simply a destination for a well-executed internal-medicine study. It is a better fit when the result gives general internists or internal-medicine subspecialists a decision they can use: a treatment choice, diagnostic strategy, prevention question, care pathway, policy consequence, equity implication, or credible reason to change established practice.

This table is a Manusights preparation model, not a JAMA checklist. Its purpose is to make the title, Key Points or abstract, results displays, and conclusion tell a traceable story of the same size.

Start with the live instructions, then make every visible component agree before upload. A paper often becomes easier to evaluate when the first page, abstract, methods, and first results table answer the same five questions: what decision is at stake, for whom, compared with what, based on which result, and within what boundary?

The package must be coherent, not merely complete. A reporting checklist cannot repair an abstract that omits the study design, a figure cannot repair an undefined primary outcome, and a persuasive submission letter cannot make a local association into a decision-grade causal finding.

These are author preparation checkpoints, not a claimed editorial timeline. They keep the final upload from becoming the first time the evidence package is read as a whole.

The shared JAMA Network instructions state that a Research Letter should not exceed 800 words, 10 references, and 2 small tables or figures; it should not include an abstract or Key Points. That format is appropriate only when the focused contribution can survive those limits. Do not shrink a decision-grade study into a letter merely to find a shorter route. Confirm that the current JAMA Internal Medicine instructions apply to your intended article type before drafting to that constraint.

Use these checks to make the manuscript's clinical claim, evidence path, and transfer boundary visible before a reader has to reconstruct them from the supplement.

Clinical relevance before technical detail

The opening should explain the decision a clinician, health system, or policy maker could make differently. That does not require a universal claim. It requires a concrete one. For example, a trial may identify a population in which an intervention changes a patient-centered outcome; an observational study may establish an association that warrants a narrower change in risk assessment or future testing. The conclusion should preserve that distinction.

Credibility of the central comparison

The methods and first results display should reveal who was compared, why the comparison is credible, how the outcome was defined, what was estimated, and how uncertainty was handled. If the claim depends on assumptions about missing data, timing, unmeasured confounding, adherence, selection, or measurement, name the most consequential assumption and show the reader how it affects interpretation.

Practice change with a stated boundary

The journal's author-facing material emphasizes clinical practice change. The useful preparation question is not whether the manuscript can say "practice-changing." It is whether the paper explains the population, setting, implementation conditions, and countervailing risks that determine where the result travels. A strong limitation paragraph does not weaken a useful result; it makes the next decision more credible.

Effective and convincing communication

The abstract, Key Points where required, first table, and discussion should not force a clinician to assemble the evidence path from scattered fragments. Put the primary comparison, outcome definition, effect estimate, and uncertainty where they can be read together. Keep exploratory analyses visibly separate from the result that carries the conclusion.

These checks focus on failures the author can correct in the draft, figures, tables, and reporting package before an editor or reviewer encounters them.

The recurring problem is not usually a missed formatting instruction. It is an evidence package that asks the reader to infer the clinical decision, the relevant comparison, or the boundary of the conclusion. The following are preparation patterns, not claims about a confidential JAMA Internal Medicine decision process.

The title promises a practice change that the methods cannot carry

Keep the conclusion inside the design.

This problem appears when the title or abstract says an intervention improves care, while the methods describe a selected observational cohort, uncontrolled implementation, or surrogate endpoint. The fix is not stronger prose. Either narrow the claim to what the study establishes or strengthen the design, analysis, and sensitivity checks needed for the broader conclusion.

Check whether your clinical claim matches the methods

The result is clinically interesting but has no named decision

Name who would do what differently.

An association, biomarker, score, or utilization pattern can be important without yet supporting a clinical recommendation. State whether the paper changes diagnosis, treatment selection, follow-up, prevention, referral, resource allocation, or the case for a future trial. If it does not yet change a decision, say what evidence would be needed next. That discipline makes an early-stage contribution more credible, not less ambitious.

Check whether the abstract states a decision consequence

The first table hides the comparison that carries the paper

Make the central evidence readable in one place.

Clinical manuscripts can contain multiple outcomes, models, and subgroups. The danger is a dense display that records activity without clarifying the result supporting the conclusion. Put the eligible population, comparator, outcome definition, effect estimate, confidence interval, and adjustment basis together. Secondary and exploratory analyses should clarify the main result, not obscure it.

Check whether your results displays make the central comparison clear

Reporting material is treated as an attachment-only task

Trace the checklist back to the draft.

The relevant reporting guidance should improve the manuscript itself. A completed file cannot compensate for unclear eligibility logic, vague outcome timing, an unexplained analysis population, missing data handled only implicitly, or a discussion that treats association as causation. Before upload, trace each high-stakes conclusion to a result, a methods choice, and a stated limitation.

Good routing is an editorial-strength choice, not a prestige concession. A specialist journal may be the better route when the contribution is technically excellent but its immediate reader and decision are tightly concentrated.